chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021 at 8:43 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 24-May-2021 at 8:43 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 51.45. No concomitant medications were reported. Batch number 025C21A administered on 24-May-2021 underwent temperature excursion with temperature range of 35 from 08:00 AM to 09:00 AM. This vial was moved to fridge on 03-May-2021 and beyond use date for the vial was reported as 02-Jun-2021. Product moved to clinic on 24-May-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported.
Extreme fatigue, shortness of breath, dry cough, diarrhea, chills, and low grade fever (100).
Feeling of lightheadedness almost right away. Went on to have shortness of breath, severe anxiety, chest tightness, confusion, brain fog, feeling uneasy and antsy, and headache.
Patient described itching and rash on skin. She would scratch her skin and break out in hives where she scratched. The itching would intensify and then go away and move to a different area of her body. 80% of the itching is on her back, neck, shoulders, and legs. She shared that the injection site is unremarkable. At time of call, she was trying to get a hold of her health care provider.
Pfizer 1st Shot gave me loud Tinnitus and hasn't stopped. I know 2 other people personally that have this same side effect; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a sponsored program (005570).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 17Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset Mar2021, outcome "not recovered", described as "Pfizer 1st Shot gave me loud Tinnitus and hasn't stopped. I know 2 other people personally that have this same side effect".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: Patient knew 2 other people personally that had this same side effect and they never had COVID ever. This is really scary stuff. Since day 2 of shot which patient got on (withheld) Day 17Mar2021. Patient was on Day 13 of this new hell with no end in site.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366081 Same reporter/drug/AE, different patient;US-PFIZER INC-2021359745 Same reporter/drug/AE, different patient
COVID-19: Patient is not short of breath and asymptomatic.  He is afebrile this morning. .He is hemodynamically stable.s.
Information has been received from a physician's assistant concerning a 9 year old female patient who on 05-MAY-2010 was vaccinated with a dose of pediatric VAQTA (lot# not reported). On 05-MAY-2010, shortly after receiving the vaccination, the patient developed pain at the injection site. No medical attention was sought. At the time of this report, the patient had recovered. Additional information has been requested.
husband was also feeling sick after eating; arthritis is getting worse after vaccine; it's hard for him to get up and down; he has gained some weight recently; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (husband was also feeling sick after eating), CONDITION AGGRAVATED (arthritis is getting worse after vaccine), MOBILITY DECREASED (it's hard for him to get up and down) and WEIGHT INCREASED (he has gained some weight recently) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery, Pacemaker insertion (cardiac), Stent placement and Heart valve replacement NOS. Concurrent medical conditions included Arthritis, Heart disorder, Cholesterol and Hypertension.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (husband was also feeling sick after eating), CONDITION AGGRAVATED (arthritis is getting worse after vaccine), MOBILITY DECREASED (it's hard for him to get up and down) and WEIGHT INCREASED (he has gained some weight recently). At the time of the report, ILLNESS (husband was also feeling sick after eating), CONDITION AGGRAVATED (arthritis is getting worse after vaccine), MOBILITY DECREASED (it's hard for him to get up and down) and WEIGHT INCREASED (he has gained some weight recently) outcome was unknown.            concomitant indications are given with unspecified drugs Treatment medications were not provided
chills, fever (102.7 F), sweats, headache, lower back pain, muscle weakness, muscle fatigue
vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.; Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. 5 vials were involved and 9 doses were administered to patients. on 02-Jun-2022 vial was initially stored in the refrigerator and vaccine was administered on 07-Jul-2022. It was reported that patient received second booster dose. The vial does not undergo any temperature excursions. Treatment details were not reported by the reporter.
Felt ill 2 days post flu vaccination; noted to have congestion, weakness and nausea 4 days later; have had fever 5 days later.
Shoulder was swollen and red mark present for 2 days after flu shot. Made an appointment to see orthopedic on 1-23-12. Doc gave me cortisone said I had frozen shoulder.
Arm red and swollen. Patient thinks the shot was given too high. But the area he points to is not a place i believe our immunizing technician would give a shot. I told patient to keep applying ice and take ibuprofen. It will go away.
Uncontrolled hypertension, injection site pain, increased myalgia pain, headache, sinus congestion, nervous, tiredness, back pain, hip pain, increased heart rate, shortness of breath, shoulder pain, muscle soreness, sleeplessness. All ongoing.
Patient's upper arm was red, itchy and swollen after receiving Prevnar 20 vaccine.  She also had pain in her arm with difficulty lifting her arm and the pain went up to her neck as well. The adverse reactions started later in the day on 3/18/2022.  She was referred to her doctor is conditions persisted.
Patient received Tdap injection in clinic on 9/25/2017 in her right deltoid. She developed tingling in thumb and fingers of right hand. Also had shooting pain down her arm from elbow to hands, with noted stiffness. This all started 24-48 hours after receiving Tdap.
pt recv vax aug96; feb97 pt was exposed to chickenpox for the third time; three weeks later feb97 the pt devel chickenpox w/ hundreds of lesions;
within 12hrs of first dose (July 21,2021) I woke up with extremely itchy & red hive on th e back of my left thigh which is still present 6wks later.
Rt arm slightly swollen, warm to touch, Advised client to take Tylenol and apply cold compress to area.
Received total of three doses of MODERNA COVID 19 Vaccine; A spontaneous report  was received from an HCP concerning an 86 years old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced medication error of received total of three doses of moderna COVID 19 vaccine.  The patient's medical history was not reported.  Concomitant medications were not reported.  On 14 Jan 2021, prior to the onset of the events, the patient received two doses of mRNA-1273 (Batch number: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient received a third dose of mRNA-1273 (Batch number: unknown) via intramuscular for prophylaxis of COVID-19 infection.  Laboratory test was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events are unknown; Reporter's Comments: This report refers to a case of an 86-year old male patient who received a total of 3 doses of mRNA-1273 (lot # not provided) with no associated AEs.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: PT fainted several minutes after vaccination and fell out of the chair. Pt regained conciousness immediatly after fall but suffered minor injuries to the face and knee (rug burn). She felt nauseous, light headed, dizzy and was pale and had cold clammy skin. She regained her complexion after 15 minutes and rested for 45 minutes before leaving.
Low grade fever and body aches from 9:30 AM until 9:40 PM (sleep). Symptoms resolved following morning (4/24).
Patient states that she received her COVID vaccine 3/2/21. She reports the next day around 3:00pm she started having severe vomiting and diarrhea. She stated that it lasted about 3-4 hours followed by another 3 hours of severe stomach cramps. She said that she felt very dehydrated and blood pressure was low after the 3-4 hours of vomiting. She reports starting to feel better after the stomach cramps stopped.
About 15 minutes after receiving my Covid-19 Moderna booster shot, I violently and uncontrollably vomited. Soon after, I developed a fever of 103F. I continued to vomit and experience uncontrollable diarrhea. Since I could not hold down motrin, (etc) to manage the fever, I became dehydrated and very dizzy. An IV therapy company came to my house, and administered 3 saline bags as well as IV drugs to the fever and nausea. After 48 hrs, with cold baths and liquid (childrens) motrin and tylenol my fever reduced to 101F, but sever GI symptoms were persistent for 6 days I could not return to the office/work until Tuesday of the following week.  Still, weeks later, I have not produced a solid bowel movement. Please note that I had zero affects from my first or second Moderna shot. This only happened with the booster.
Patient arrived with no flu like symptoms and had no complaints of illness or discomfort.  After the injection the patient was observed and had no signs of adverse affects.
After her third dose of the COVID-19 Vaccine, she got a fever; not doing well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "cancer" (unspecified if ongoing), notes: had cancer. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (First dose, MANUFACTURER UNKNOWN), for covid-19 immunization; Covid-19 vaccine (Second dose, MANUFACTURER UNKNOWN), for covid-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "After her third dose of the COVID-19 Vaccine, she got a fever"; MALAISE (non-serious), outcome "unknown", described as "not doing well".  Additional information: Patient had cancer, she is not in remission and is active. After her third dose of the COVID-19 Vaccine, she got a fever. Reporter was not sure if it's cancer related stuff, also reported that patient was not doing well.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
no appetite; body week; feel sick; Chills; PUKE; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ASTHENIA (body week), MALAISE (feel sick), CHILLS (Chills) and VOMITING (PUKE) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (body week), MALAISE (feel sick), CHILLS (Chills) and VOMITING (PUKE). At the time of the report, DECREASED APPETITE (no appetite), ASTHENIA (body week), MALAISE (feel sick), CHILLS (Chills) and VOMITING (PUKE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.  This case concerns a 63-year-old female with serious unexpected events of decreased appetite, asthenia, malaise, chills and vomiting. Latency within 1 day after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non significant follow up; Sender's Comments: This case concerns a 63-year-old female with serious unexpected events of decreased appetite, asthenia, malaise, chills and vomiting. Latency within 1 day after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
acute GI bleed  SARS CoV-2, PCR, Rapid, V(!): Detected updated patient on COVID-19 diagnosis and what this changes for this GI bleed at this time.
metallic taste in mouth/licks hand, it takes metallic; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in mouth/licks hand, it takes metallic) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Depression, Cholesterol and Acid reflux (oesophageal). Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), TRIAMTERENE for Blood pressure high, ATORVASTATIN for Cholesterol, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, LISINOPRIL for Hypertension, MULTIVITAMIN & MINERAL for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth/licks hand, it takes metallic). At the time of the report, DYSGEUSIA (metallic taste in mouth/licks hand, it takes metallic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Reaction on Right Thigh.  2 mm diameter red papule on right thigh.  Non tender.  Documented on 8/26/2019 visit to primary care office by Dr.
Pain, rash, swelling, itchiness at/around injection site. Slight tingling from elbow to fingertips on same arm as injection. This feeling is similar to when a body part falls asleep and then gets tingly when waking up. Time and ice pack are the treatment. Still experiencing event a day after initial onset.
pt recvd vax w/in 24hrs p/vax exp hives;tx DPH spray;still has hives
10/28 flu shot @ store. 10/29 flu-like sx: myalgia, sore throat 11/1 pain, tenderness @ site. ER/admit 11/10 - 12/1 abscess L deltoid --> staph aureus.
Fever and chills, then very painful right shoulder joint and very swollen lymph in right axilla.
Arm hurt; not feeling well / Feeling awfull; Hot flashes; Felt Hot; trouble sleeping; pain; redness; swelling at injection site; myalgia; fatigue; headache; fever; Gastrointestinal symptoms; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hot flashes.   On 4th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 4th September 2019, 1 hr after receiving Shingrix, the patient experienced pain in arm, feeling unwell, hot flashes, feeling hot, difficulty sleeping, injection site pain, injection site erythema, injection site swelling, myalgia, fatigue, headache, fever and gastrointestinal symptom nos. On an unknown date, the outcome of the pain in arm, feeling unwell, hot flashes, feeling hot, difficulty sleeping and injection site pain were recovering/resolving and the outcome of the injection site erythema, injection site swelling, myalgia, fatigue, headache, fever and gastrointestinal symptom nos were unknown.   It was unknown if the reporter considered the pain in arm, feeling unwell, hot flashes, feeling hot, difficulty sleeping, injection site pain, injection site erythema, injection site swelling, myalgia, fatigue, headache, fever and gastrointestinal symptom nos to be related to Shingrix.  Additional details were provided as follows: The patient reported that an hour after the injection, her arm hurt and she did not feel well which she described as "feeling awful." The patient felt hot and she was not certain if it was related to her ongoing hot flashes or from the vaccine. The patient attempted to lift a box with 4 items inside and her arm hurt worse and worse and she had trouble sleeping last night. The patient also experienced pain, redness, swelling at the injection site, myalgia, fatigue, headache, fever and gastrointestinal symptoms. The patient consented to follow up.
Isolated fever to 103.2 on 2/4 - resulted in hospitalization.  He was febrile to 102 on arrival with WBC count 11.9 with a L shift, leukocytosis resolved within 2 days, no further fevers documented afte rthat.  CXR with most likely atelectasis.  Pt unable to provide history, staff not observing respiratory symptoms, pt on room air. Initially started on vanc/zosyn despite negative procalcitonin -> AKI -> repeat procalcitonin minimally elevated (likely due to vanc/zosyn combination), stopped antibiotics, AKI resolved and procalcitonin again normal.
Flu like symptoms - achy joints. tired, listless, chills and sweats. My wife and I experienced similar symptoms for about 24 hours after getting the flu shot.
recipient reported feeling of acute hot/cold feeling 5min after the vaccination, which went away after a few minute. the next day by evening feel fatigue and muscle aches lastly to today Tues. fatigue and muscles aches have improved a little but still feeling under the weather. Denied fever or other reactions
Severe erythematous macular-papular rash with vesicles and bullae across left flank (left abd, left side, and left lower back along dermatome) typical of herpes zoster. No pain. BENADRYL - per MD note on 4/12/17 and 4/13/17.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Nov2021 as dose 2, single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation; janssen covid-19 vaccine (JANSSEN COVID-19 VACCINE), on 06Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Interchange of vaccine product" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information :Patient received vaccine in 2 weeks of vaccination. Also received other medication in 2 weeks of vaccination.  Anti-viral details: Product- COVID 19 Treatment, Brand- Paxlovid, Treatment start date- 20Mar2022, Treatment stop date- 24Mar2022, Lot number- GA8204, Indication- Treatment of COVID-19  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.